[go: up one dir, main page]

Yarnell et al., 1969 - Google Patents

Studies of tumour invasion in organ culture: II. Effects of enzyme treatment

Yarnell et al., 1969

Document ID
3775107284045939078
Author
Yarnell M
Ambrose E
Publication year
Publication venue
European Journal of Cancer (1965)

External Links

Snippet

Using the technique already described for studying the invasion of BHK21 Py cells into foetal mouse heart explants, trypsin and neuraminidase were used to remove surface material from the invading cells. Pretreatment with neuraminidase reduced the capacity of …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation; Therapies using these preparations
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups

Similar Documents

Publication Publication Date Title
Yarnell et al. Studies of tumour invasion in organ culture: II. Effects of enzyme treatment
US4042457A (en) Preparation of tissue invasion inhibitor and method of treatment utilizing the inhibitor
EP2589389B1 (en) Method for producing a biologically active complex. biologically active protein/polypeptide complex
EP0029893B1 (en) Process for concentration of tumor-inhibiting substances
CN116173175A (en) Preparation method of blood perfusion filler for treating immunodeficiency-induced tumors
JPH03503530A (en) Human tumor therapeutic drug and its manufacturing method
US4952399A (en) Pharmaceutical composition which inhibits the growth of a tumor
Geraerts et al. Heterogeneity of peptides released by electrically active neuroendocrine caudodorsal cells ofLymnaea stagnalis
Larsen et al. Inhibitory effect of polycations on the transplantability of mouse leukaemia reversed by heparin
Baruah Cellular reactions following tumor growth with special reference to plasma-cellular response
US4193992A (en) Process for the preparation of defibrinated and lyophilized placental cells
KR102580940B1 (en) Extraction Method of high purity Poly Deoxy Ribo Nucleotide from meats of Salmonid fish
Guskov et al. Genetic effects of hyperbaric oxygen therapy
CN109793748A (en) A kind of prevention and treatment cerebral ischemia causes the drug and its preparation of inflammatory reaction
RU2346040C2 (en) Composition for inhibiting proliferation of structure enclosed mammal stem cells and methods of inhibiting proliferation (versions)
DE60304989T2 (en) Compositions containing fetal hemoglobin and bacterial endotoxin and optionally additional fetal liver components
WO2012166004A1 (en) Protein-polypeptide complex with a specific activity on the nervous system, process for preparing same and pharmaceutical composition on the basis thereof
Fisher et al. Further observations concerning effects of antilymphocyte serum on tumor growth: with special reference to allogeneic inhibition
Castiglioni et al. First results of tissue culture in Drosophila
Danilov et al. Morphological characteristics of the trigeminal node of rats when cryopreserved placenta is introduced
Ghanmi et al. Modulatory effect of metal lons on the immune response of fish: In vivo and in vitro influence of MnCl2 on NK activity of carp pronephros cells
Hurme et al. Highly increased natural killer cell number and lytic activity in the murine peripheral blood and lungs after interferon induction in vivo
CN100383183C (en) Algae enzyme hydrolyzate and production method thereof
RU2563816C1 (en) Method for producing immune stimulant
MATUDA et al. Isolation of the mitosis promoting substance, oncotrephin, from rat ascites hepatoma (AH 130)